GSK（葛兰素史克）中国研发中心总裁臧敬五造假被调查

MP4

臧敬五否认论文造假指控，或将采取法律行动

针对当前指控，臧敬五表示震惊，并否认目前的指控。“我必须说，我非常失望，因为我从没有参与数据的制作。”臧敬五补充道，“作为通讯作者，我应该承担一定责任，但并非目前的指控”。


第一作者刘学斌表示，他已经从GSK辞职，并强调有关的数字有问题的数据是不正确的文件描述，因为他再提交出版时，忘了更新手稿。“当时我们有点匆忙。但是所有数据都是真实的，其数据均来自健康人”，并且表示其数据在任何时间任何实验室都经得住考验。


另外，刘学斌表示，并没有签署撤销论文。同时，刘学斌称，臧敬五并未实现（realize）论文的错误，也未参与参与数据分析制作。


当被问及是否会对GSK采取法律行动时，臧敬五表示，“我在考虑我的选择，[将]看看我能做些什么（I am considering my options and [will] see what I can do.”）。

http://www.bio360.net/news/show/5614.html

zhsyh

学术骗子比盗窃、敲诈更可恶，他欺骗人们对学术的尊重

MP4

http://www.bioon.com/industry/mdnews/571109.shtml
声明

对于那些企图恶意抹黑、诽谤、中伤我，以及企图诋毁 GSK 声誉，尤其是企图刻意损毁臧敬五先生及其他中国同事名誉的人及言论表示最严重的谴责。

liver411

葛兰素史克声明已因论文造假开除臧敬五

　　葛兰素史克发表声明，确认其中国研发中心主任臧敬五等人在2010年发表的
《自然·医学》论文造假。通讯作者臧敬五已被开除，第一作者刘学彬辞职，其
他三个作者离职。声明原文如下：

　　GSK statement regarding 2010 Nature Medicine study
　　June 10, 2013
　　GSK and Nature Medicine both received some weeks ago the same
information alleging misrepresentation of data in a research paper
written by scientists at GSK's China research centre and published in
Nature Medicine in 2010. The published study was from preclinical,
early stage research and did not directly involve patients.
　　When these allegations came to light we immediately contacted the
journal to tell them that we were taking the charges seriously and
would be investigating thoroughly. Regretfully, our investigation has
established that certain data in the paper were indeed misrepresented.
We've shared our conclusion that the paper should be retracted and are
in the process of asking all of the authors to sign a statement to
that effect, according to Nature Medicine's procedure.
　　We have taken action in response to these findings, which we have
shared with our employees. One individual has been dismissed from GSK;
a second has submitted his resignation and three others have been
placed on administrative leave, pending a final review.
　　We are committed to the highest ethical and scientific standards
and regulators, physicians and patients can have confidence in the
research we carry out.